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Abstract.  The BC3H1 cell line has been used widely 
as a model for studying regulation of muscle-related 
proteins,  such as the acetylcholine receptor,  myo- 
kinase,  creatine kinase,  and actin.  These cells, derived 
from a nitrosourea-induced mouse brain neoplasm, 
have some of the morphological characteristics  of 
smooth muscle and have been shown to express the 
vascular smooth muscle isoform of ot-actin.  To provide 
further information about the contractile protein 
phenotype of BC3H1 and to gain additional insights 
into the possible tissue of origin of these cells, we 
have examined the expression of a battery of contrac- 
tile protein genes.  During rapid growth,  subconfluent 
BC3H1 cells express the nonmuscle isoform of 
ot-tropomyosin (t~-Tm) and the nonsarcomeric isoforms 
of myosin heavy and light chains (MHCs and MLCs, 
respectively), but do not express troponin T(TnT). 
However, when BC3H1 cells differentiate in response 
to incubation in serum-deprived medium or upon ap- 
proaching confluence, they express TnT as well as sar- 
comeric muscle isoforms of MHC, MLC 2 and 3, 
a-Tm,  and ot-actin.  These results suggest that BC3H1 
is a  skeletal muscle cell line of ectodermal origin that 
is defective for commitment to terminal differentiation. 
T 
n~. BC3H1  cell line  (Schubert et al.,  1974) has re- 
ceived considerable attention  as a model for studying 
muscle cell differentiation  and the regulation  of mus- 
cle-related  proteins.  BC3H1 cells can be induced to differen- 
tiate by removal of growth factors from the culture medium 
or by allowing  cultures to reach confluence.  Under these 
conditions,  BC3H1  cells accumulate a  variety  of muscle- 
specific  gene products,  such  as muscle creatine  phospho- 
kinase  (MCK) ~ (Schubert  et  al.,  1974; Munson  et  al., 
1982; Olson et al., 1983), myokinase (Schubert et al., 1974), 
and a-actin (Strauch  and Rubenstein,  1984; Strauch  et al., 
1986) as well as the nicotinic  acetylcholine (Patrick et al., 
1977; Olson et al., 1984) and insulin receptors (Standaert et 
al.,  1984).  Differentiation  is  reversible,  either  by adding 
mitogens to the culture medium (Lathrop et al., 1985; Spizz 
et al.,  1986) or by replating  cells in  serum-rich  medium 
(Munson et al.,  1982; Olson et al.,  1983). 
The BC3H1 cell line was originally  isolated  from mouse 
brain neoplastic tissue and characterized  by Schubert et al. 
(1974). Results of morphological, biochemical, and physio- 
l. Abbreviations usedin thispaper:  LSM, low serum medium; MCK, mus- 
cle creatine kinase;  MHC, myosin heavy chain; MLC,  myosin light chain; 
RLC,  regulatory  light chain; a-Tm, c~-tropomyosin; TnT, troponin T. 
logical analyses led to the suggestion that BC3H1 cells were 
of smooth muscle origin.  This concept was further strength- 
ened by the demonstration  that differentiation  of BC3H1 
resulted  in  the  accumulation  of smooth  muscle-specific 
tr-actin (Strauch and Rubenstein,  1984; Strauch et al., 1986; 
Wang and Rubenstein,  1988). In contrast, the expression of 
MCK and the nicotinic  acetylcholine receptor in  BC3H1 
suggested these cells behaved more like skeletal muscle.  In 
addition,  it has recently been shown that  BC3H1 cells ex- 
press  a  skeletal  muscle-type  voltage-gated  Ca  2+  channel 
(Caffrey et al., 1987) as well as the skeletal muscle isoform 
of c~-actin (Reeser,  J.  C., and A.  R. Strauch,  unpublished 
results).  None of these markers,  however, is specific for stri- 
ated skeletal muscle. Given the widespread use of the BC3H1 
culture system as an in vitro model for studying the differen- 
tiation and regulation  of muscle-specific genes, it is impor- 
tant to establish  the phenotype of muscle-specific gene ex- 
pression in BC3H1 and to determine whether this phenotype 
supports a smooth or skeletal muscle origin for this cell line. 
Accordingly, we have performed RNA blot and S1 nuclease 
analyses using specific eDNA probes for a variety of  contrac- 
tile proteins representing  both the thin and thick filaments. 
We now report that subconfluent,  growing BC3H1 cells ex- 
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the nonsarcomeric isoforms of myosin heavy and light chains 
(MHCs and MLCs, respectively), but do not express tropo- 
nin T  (TnT). However, when BC3H1  ceils differentiate in 
response to incubation in serum-deprived medium or upon 
approaching confluence, they express TnT as well as  sar- 
comeric muscle isoforms of MHC, MLC 2 and 3, a-Tm, and 
c~-actin. These results suggest that the BC3H1 cell line most 
closely resembles a skeletal muscle cell that is defective for 
commitment to terminal differentiation. 
Materials and Methods 
Cell Culture 
The BC3H1  mouse cell line (Schubert et at.,  1974) was a generous gift of 
Dr.  Eric N. Olson (Department of Biochemistry and Molecular Biology, 
University of Texas, M. D. Anderson Hospital and Tumor Institute). Cul- 
tures were grown on 15-cm tissue culture dishes in DME containing 20% 
FCS, 100 U/ml penicillin, and 100 ttg/ml streptomycin as described by OI- 
son et al. (1983). The medium was changed every 2 d. To minimize differen- 
tiation of BC3H1 cells and induction of contractile protein genes, cells were 
passaged while no more than 75%  confluent. To  initiate differentiation, 
medium containing 20%  serum was removed and replaced with medium, 
designated as LSM (low-serum medium; Lathrop et al.,  1985),  containing 
DME and F12 in a ratio of 3:1, 50 t~g/ml transferrin, 250 ~g/ml BSA, 0.25 % 
FCS, and antibiotics. 
RNA Preparation and Blot Hybridization 
Total RNA was extracted from BC3H1 cultures by the gnanidinium isothio- 
cyanate/CsCl procedure (Chirgwin et al.,  1979).  15 t~g of total RNA was 
size fractionated by electrophoresis on 1% agarose gels in 200 mM 4-mor- 
pholinepropanesulfonic  acid, pH 7.4, 1 mM EDTA, and 3 % formaldehyde. 
Transfer to nitrocellulose and hybridization to 3~P-labeled DNA probes was 
as described (Thomas,  1980).  Filters were hybridized at 42°C for 14 h in 
a cocktail containing 50% formamide, 5x SSC (Ix  =  0.15 M NaCI, 0.015 
sodium citrate), 2 x  Denhardt's solution, 0.1% SDS, 0.025 M sodium phos- 
phate, and 50 mg/ml calf thymus DNA.  At the end of hybridization, the 
filters were washed in 0.1× SSC at 55°C unless otherwise indicated. Filters 
were exposed to Kodak XAR-5 film for 2 d at -70°C with one intensifying 
screen. 
Preparation of eDNA Probes 
The following eDNA probes were labeled by nick translation (Rigby et al., 
1977) using [s2P]dATP  and [32p]dCTP  (400 Ci/mmol; Amersham Corp., 
Arlington Heights, IL) to a specific activity of ,M0  s cpm/#g DNA: pMCK- 
4 (rat skeletal MCK; Benfield et al., 1984); pAC269 (chicken skeletal mus- 
cle ot-actin; Schwartz et al., 1980); pT1 (ot-tubulin;  Valenzuela et al., 1981); 
rat fast skeletal muscle eDNA clones (Garfinkel et al., 1982); pTnT15 (TnT); 
pMLC-84 (MLC 1); pMLC2-18 (MLC 2); a eDNA clone encoding rat stri- 
ated muscle a-Tin (Wieczorek et al.,  1988);  a  clone encoding a  myosin 
regulatory light chain (RLC) isolated from a rat aortic smooth muscle cell 
eDNA library (Taubman et al.,  1987);  pMHC25  (rat embryonic MHC; 
Medford et al., 1980); and SMHC 29 (rabbit smooth muscle MHC; Nagai 
et al.,  1988).  Synthetic oligonucleotide probes comprised of the first 87 
nucleotides of the 3' untransla~l sequences of mouse skeletal a-actin (Hu 
et al.,  1986) and the first 55 nucleotides of the 5' untranslated sequences 
of mouse cardiac ot-actin  (Minty et al.,  1983)  were end-labeled with T4 
polynucleotide kinase and [s2P-3,]ATP. 
$1 Nuclease Mapping 
RNA-DNA hybridization followed by SI  nuclease mapping analysis was 
performed as previously described (see Taubman et al.,  1987; Wieczorek 
et al., 1988).  The probes used were generated by digestion with restriction 
endonucleases and  labeled at  the 5' end with [32P-3,]ATP and T4  poly- 
nucleotide kinase. Total cellular RNA (25 ~g) was hybridized to 2  ×  104 
cpm of  probe in 25/zl of 80% deionized formamide, 400 mM NaCI, 10 mM 
Pipes, pH 6.4, 0.05%  SDS, 1 mM EDTA.  The hybridization mixture was 
incubated at 65°C for 1 h, the temperature was adjusted to 60°C, and the 
incubation was continued for 16 h.  SI nuclease (100 U) in 300 #1 of 200 
mM NaCI, 20 mM sodium acetate, pH 4.5,  3 mM ZnSO4  was added to 
each sample, and the samples were incubated at 25°C for 1 h. The reaction 
was terminated with 10 mM EDTA and precipitated with ethanol. Dried 
pellets were dissolved in 90% formamide and electrophoresed on 6% poly- 
acrylamide-8 M urea sequencing gels. Gels were dried and exposed for au- 
toradiography on Kodak X-Omat AR film. 
Results 
BC3HI  cells were plated at low density (4  ×  1@ celis/15- 
cm dish) and subsequently grown in 20% FCS. At the indi- 
cated  times,  duplicate  cultures  were  either harvested  or 
switched  to  LSM,  (see  Materials  and  Methods)  and  in- 
cubated for an additional 48 h. To assay for the accumulation 
of muscle-specific mRNAs,  blot hybridizations were per- 
formed using a variety of eDNA probes encoding muscle- 
related proteins. 
To confirm that the BC3H1 cells used in this study behaved 
as previously reported, the expression of creatine kinase and 
actin mRNA were examined, mRNA encoding MCK was ab- 
sent in subconfluent, growing cultures, but its accumulation 
was  induced when BC3H! cultures approached confluence 
(Fig.  1 A,  lanes 1-5) or when subconfluent cultures were 
switched to LSM (Fig.  1 A, lanes 6-10). mRNA compatible 
in size with either of the nonmuscle actin isoform(s), ~3 and 
7, was found in subconfluent, growing BC3H1 cultures (Fig. 
1 B,  lanes  1 and 2).  However, when cultures approached 
confluence (Fig.  1 B, lane 3) or when subconfluent cultures 
were switched to LSM (Fig.  1 B, lanes 6-10), accumulation 
of an mRNA compatible in size with an a-actin isoform was 
induced, while expression of the larger/3 or 3' isoform(s) was 
no longer apparent. These results are similar to those dem- 
onstrated by other laboratories (Olson et al.,  1983;  Strauch 
et al.,  1986).  In contrast, levels of c~-tubulin mRNA were 
slightly diminished when BC3H1 cells reached confluence 
or were switched to LSM (Fig. 1 C), demonstrating that the 
increases in MCK and u-actin mRNA levels did not simply 
represent a generalized increase in message levels. 
Differentiated  BC3H1 Cells Produce TnT mRNA 
TnT is a critical component of the sarcomeric contractile ap- 
paratus. In contrast, TnT does not play a role in smooth mus- 
cle  contraction (for review  see  Adelstein  and  Eisenberg, 
1980).  Neither TnT protein nor mRNA has been found in 
smooth muscle tissue or cells (Medford et al.,  1984; Mar- 
ston and Smith, 1985). TnT mRNA was not detected in 25- 
30% confluent proliferating BC3H1 cells (Fig. 2 A, lane 1) 
and was detected in only trace amounts at •50  % confluence 
(Fig. 2 A, lane 2). However, high levels of TnT mRNA were 
found when BC3H1 cultures approached confluence (Fig. 2 
A, lanes 3-7) or when subconfluent cultures were incubated 
in LSM (Fig. 2 B). Differentiated BC3H1 cells thus synthe- 
size an mRNA found only in sarcomeric tissues or cells. 
Differentiation  of BC3H1 Cells Results 
in a Switch from the Nonmuscle to Striated Muscle 
Isoform of  ~-Tm 
Rat ~-Tm is encoded by a single gene whose transcripts are 
alternatively  spliced  to  produce  distinct  nonmuscle  and 
smooth  and  striated  muscle  isoforms  (Wieczorek et  al., 
1988). The nonmuscle and smooth muscle mRNAs are the 
same size and are significantly larger than the striated muscle 
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tions were performed using 15 #g of  total cellular RNA and hybrid- 
ized with the following  cDNA probes (see Materials and Methods): 
(A) striated MCK; (B) chicken skeletal muscle ot-actin; and (C) 
a-tubulin. BC3H1 cultures were plated at low density in DME con- 
mining 20% FCS. Cultures were grown in the same medium and 
harvested 2, 3, 4, 5, and 7 d after plating (lanes 1-5, respectively). 
Duplicate cultures were harvested after a 48-h incubation in LSM 
beginning 2, 3, 4, 5, and 7 d after plating (lanes 6-10, respectively). 
Cultures maintained in DME +  20% FCS appeared confluent 5 d 
after plating. 
isoforms. This is due to the presence in smooth muscle and 
nonmuscle  transcripts  of  an  alternative  3'  exon  with  a 
significantly larger 3' untranslated region than that of  the stri- 
ated  muscle-specific  3'  exons  (Ruiz-Opazo  et  al.,  1985; 
Wieczorek et al.,  1988). As demonstrated (Fig.  3 A, lanes 
1-3),  subconfluent,  growing  BC3H1  cultures  express  an 
a-Tm mRNA of a size compatible with either the nonmuscle 
or smooth muscle isoform. To further establish the identity 
of the hybridizing species,  S1  nuclease mapping was per- 
formed using probes which differentiate between the non- 
muscle  and  smooth  muscle  isoforms  (Wieczorek  et  al., 
1988). These two isoforms differ only at the 5' end, where 
the smooth muscle isoform contains exon 2  while the non- 
muscle (and striated muscle) isoform uses exon 3. Fig. 4 A 
shows  the  results  of S1  mapping  using  a  smooth  muscle 
cDNA  restriction fragment.  Full protection of this  probe 
(355 nucleotides; e.g., uterus, Fig. 4 A, lane 4) is seen only 
with smooth muscle,  while partial protection (116 nucleo- 
tides; e.g., LsE9, Fig. 4 A, lane 3) is seen with striated and 
nonmuscle tissues (Wieczorek et al., 1988). RNA from sub- 
confluent, proliferating BC3H1 cells (Fig. 4 A, lane 5) pro- 
duced mainly partial protection, consistent with the nonmus- 
cle isoform. Fig. 4 B shows the results of S1 mapping using 
a striated muscle cDNA restriction fragment. Full protection 
of this probe (355 nucleotides; e.g., L6F~, Fig. 4 B, lane 3) 
is  seen with  striated and  nonmuscle tissues,  while partial 
protection (116 nucleotides; e.g., uterus; Fig. 4  B, lane 4) 
is seen with smooth muscle (Wieczorek et al., 1988). RNA 
from subconfluent, proliferating BC3H1 cells (Fig. 4 B, lane 
5) produced full protection, again consistent with the non- 
muscle isoform. 
The above results suggest that the predominant a-Tm spe- 
cies produced by growing BC3H1 cells is the nonmuscle iso- 
form. Upon reaching confluence, BC3H1 cultures stopped 
producing this  mRNA  and  began to  accumulate an u-Tm 
mRNA of a size compatible with a striated muscle isoform 
(Fig. 3 A, lanes 4-7). S1 nuclease mapping (Fig. 4, lanes 6 
and 7) showed no change in the splicing pattern at the 5' end, 
confirming that this was a striated muscle isoform. This iso- 
form switch was also noted when subconfluent cultures were 
switched to LSM (Fig. 3 B). Similar changes in ct-Tm splic- 
ing patterns (i.e.,  from nonmuscle to striated muscle iso- 
forms) are seen upon differentiation of striated muscle cells 
(Wieczorek et al.,  1988; our unpublished observations). 
Differentiated BC3HI Cells Produce Skeletal Muscle 
MLC 3 mRNA 
Fast skeletal muscle contains three types of MLC: two "al- 
kali" light chains, MLC 1 and MLC 3, and one RLC, MLC 
2.  In contrast, smooth muscle contains one alkali and one 
regulatory light chain. The rat skeletal alkali light chains are 
generated by alternative splicing of  primary transcripts from 
a  single gene containing two promoters (Periasamy et al., 
1984;  Strehler et al.,  1985).  This gene is  expressed in a 
developmental and tissue-specific manner (Whalen et al., 
1981; Periasamy et al.,  1984) and, in particular, is not ex- 
pressed in smooth muscle. As shown (Fig. 5 A, lanes 1-3), 
subconfluent growing BC3H1 cultures do not contain detect- 
able amounts of skeletal muscle alkali light chain mRNAs. 
However, upon reaching confluence, high levels of MLC 3 
mRNA were detected (Fig. 4 A, lanes 4-7). No mRNA cor- 
responding in size to MLC 1 was detected at any time in cul- 
ture.  MLC  3  mRNA  was  also  induced by switching  sub- 
confluent cells to LSM (Fig. 5 B). The pattern of expression 
is similar to that seen in the embryonic skeletal muscle line 
L6E9 (Nadal-Ginard,  1978),  where only MLC 3 mRNA is 
expressed (our unpublished observations). In other skeletal 
muscle cells both MLC 1 and MLC 3 mRNAs are expressed 
with the ratio of MLC 3 to MLC 1 highest in cells derived 
from adult  skeletal muscle  (Periasamy et al.,  1984).  The 
presence or absence of smooth  muscle alkali  light  chain 
mRNA in BC3H1 cultures could not be assayed because of 
the  lack of cross-hybridization of smooth  muscle mRNA 
with the skeletal muscle probes and because of the lack of 
availability of specific cDNA probes for mouse smooth mus- 
cle alkali light chains. 
Figure 2. Expression ofTnT mRNA. RNA blot hybridizations were 
performed using the rat TnT cDNA probe. (A) BC3H1 cultures were 
plated at low density and grown in DME +  20% FCS for 2, 3, 4, 
5, 7, 9, and ll d (lanes 1-7, respectively). Cultures appeared con- 
fluent 5 d after plating. (B) Duplicate cultures were grown in DME 
+  20% FCS and subsequently switched to LSM for 48 h, 2, 3, 4, 
5, 7, 9, and 11 d after plating (lanes 1-7, respectively). 
Taubman et al. Sarcomeric  Muscle-specific  Gene Expression in BC3HI  1801 Figure 3.  Expression  of cz-Tm mRNA.  RNA blot hybridizations 
were performed using the rat ¢x-Tm  cDNA probe. (A) BC3HI cul- 
tures were plated at low density and grown in DME +  20% FCS 
for 2, 3, 4, 5, 7, 9, and 11 d (lanes 1-7, respectively). Cultures ap- 
peared  confluent  5 d  after plating.  (B)  Duplicate  cultures  were 
grown in DME  +  20%  FCS and subsequently switched to LSM 
for 48 h 2, 3, 4, 5, 7, 9, and  11 d after plating (lanes 1-7, respec- 
tively). NM/SM, nonmuscle and smooth muscle isoforms of c~-Tm. 
SK, skeletal muscle isoform. 
Differentiated BC3H1 Cells Contain both Sarcomeric 
and Nonsarcomeric Myosin RLCs 
The rat skeletal muscle RLC, MLC 2, gene is expressed in 
a  developmental  and  tissue-specific  manner  (Devlin  and 
Emerson,  1978; Shani et al.,  1981). Under the conditions of 
hybridization used in this experiment, the rat MLC 2 probe 
does not cross-hybridize with  RNA derived  from smooth 
muscle tissues or cells, but does cross-hybridize with other 
sarcomeric MLC 2  mRNAs,  such  as  those  isolated  from 
cardiac muscle (our unpublished observations). Subconflu- 
ent growing BC3H1 cultures contained very small or unde- 
tectable amounts of MLC 2  mRNA (Fig 6 A,  lanes 1 and 
2).  However as cultures approached confluence, increasing 
amounts of mRNA accumulated which hybridized with the 
rat skeletal muscle MLC 2 probe (Fig. 6 A, lanes 3-7). High 
levels of MLC 2  mRNA were induced  by switching  sub- 
confluent cells to LSM (Fig. 6 B). These results demonstrate 
that, in addition to accumulating sarcomeric MLC 3 mRNA, 
differentiated BC3H1 cells also contain a sarcomeric isoform 
of the myosin RLC, MLC 2. 
We have recently isolated a cDNA clone from rat aortic 
smooth muscle cells which corresponds to a nonsarcomeric 
myosin RLC  (Taubman et  al.,  1987).  The  corresponding 
mRNA is larger than that encoding the skeletal muscle MLC 
2 and is readily distinguished from MLC 2 mRNA on RNA 
blots. This mRNA is found in a wide variety of muscle and 
nonmuscle tissues and thus does not exhibit the tissue speci- 
ficity found for other contractile protein genes (Taubman et 
al.,  1987).  Whether this cDNA encodes a smooth muscle- 
or nonmuscle-specific RLC has yet to be conclusively deter- 
mined. Growing, but subconfluent, BC3H1 cells expressed 
high levels of RLC mRNA (Fig.  6  C).  As these cells con- 
tinued to grow in culture,  smaller amounts of RLC mRNA 
were detected.  By switching subconfluent cells to LSM,  a 
rapid decrease in the levels of this mRNA was noted (Fig. 
6 D) corresponding to levels seen in postconfluent density ar- 
rested ceils (Fig. 6 C). This pattern of expression is opposite 
Figure  4.  SI  nuclease  analysis  of  c~-Tm 
mRNA expression.  (Lane I) probe;  (lane 
2) tRNA; (lane 3) L6E9 rat skeletal muscle 
myoblasts; (lane 4) rat uterus;  (lanes 5-7) 
BC3H1  cells  at  30%  confluence,  90% 
confluence, and 2 d after 100% confluence, 
respectively. (A) The smooth muscle (SM) 
cDNA Eco  RI-Pst I  restriction  fragment 
with a polylinker tail (hatched) depicted at 
the bottom was 5'end labeled at a nucleotide 
corresponding to codon 120. Significant full 
protection of  this probe (355 nt) is seen only 
with smooth muscle samples, while partial 
protection  (116 nO is  seen  in striated  and 
nonmuscle  samples  (Wieczorek  et  al., 
1988). (B) The striated muscle cDNA re- 
striction  fragment  with  a  polylinker  tail 
(hatched) (SK) depicted at the bottom was 
5' end labeled at a nucleotide corresponding 
to codon  120. Full  protection  (355 nO is 
seen with striated and nonmuscle samples 
while partial protection (116  nO is seen with 
smooth muscle (Wieczorek et al.,  1988). 
The Journal of Cell Biology, Volume 108', 1989  ,  1802 Figure 5. Expression of skeletal muscle MLC 1 and MLC 3. RNA 
blot hybridizations  using  the  rat skeletal muscle  MLC  1 cDNA 
probe. MLC 1 and 3 are transcribed from the same gene and both 
mRNAs can be identified using the MLC 1 transcript. Only MLC 3 
is seen in BC3H1 cultures under the conditions used.  (A) BC3HI 
cultures were plated at low density and grown in DME + 20% FCS 
for 2, 3, 4, 5, 7, 9, and 11 d (lanes 1-7, respectively). Cultures ap- 
peared  confluent  5 d  after plating.  (B) Duplicate  cultures  were 
grown in DME  +  20%  FCS and subsequently  switched to LSM 
for 48 h, 2, 3, 4, 5, 7, 9, and 11 d after plating (lanes 1-7, respec- 
tively). 
The results of hybridization with the embryonic skeletal 
muscle MHC probe are opposite those seen with the smooth 
muscle MHC cDNA. In particular, the strongest signal de- 
tected with the smooth muscle probe (Fig. 7 A, lane 1) oc- 
curs at a time when only a trace signal is noted with the em- 
bryonic skeletal MHC probe (Fig. 7 B, lane 1). This argues 
strongly that the predominant MHC mRNA detected by the 
smooth muscle MHC cDNA in growing subconfluent BC3H1 
cultures is a nonsarcomeric isoform(s). In contrast, growth- 
arrested BC3H1  cells predominantly express a  sarcomeric 
muscle  MHC  isoform(s).  Differentiation  of BC3H1  cells 
thus appears to be accompanied by the induction of a sarco- 
meric and deinduction of a  nonsarcomeric MHC gene. 
BC3H1 Cells Express Sarcomeric lsoforms of  a-Actin 
It has recently been reported that induction of BC3H1 cells 
results not only in the synthesis of vascular smooth muscle 
ct-actin, but of skeletal a-actin as well (Reeser, J.  C., and 
A.  R.  Strauch,  unpublished  results).  RNA  from  BC3H1 
cells was hybridized to probes specific for the 5' untranslated 
end of mouse cardiac t~-actin (Minty et al., 1983) and 3' un- 
translated end of mouse skeletal ot-actin (Hu et al.,  1986) 
that seen in rat aomc smooth muscle cells, where increasing 
amounts of RLC mRNA are detected at confluence (Taub- 
man et al.,  1987).  Thus,  BC3H1 cells express both sarco- 
meric and nonsarcomeric forms of myosin RLC,  with the 
former present predominantly in the growth-arrested, differ- 
entiated state and the latter predominantly during rapid cell 
growth. 
Differentiation of  BC3H1 Cells Is Accompanied 
by the Induction of  a Sarcomeric lsoform and the 
Deinduction of  a Nonsarcomeric lsoform of  MHC 
Rat MHCs are members of a multigene family and are ex- 
pressed in a developmental and tissue-specific fashion (for 
review see Mahdavi et al.,  1986).  RNA from BC3H1  cul- 
tures was hybridized with a cDNA probe encoding a rabbit 
aortic MHC isoform (gift of M.  Periasamy, Department of 
Physiology and Biophysics, University of Vermont College 
of Medicine).  At  high  stringency,  this  cDNA  hybridizes 
strongly only to RNA derived from smooth muscle cells or 
tissues, but does hybridize weakly to RNA from nonmuscle 
or striated muscle (Nagai et al.,  1988; our unpublished ob- 
servations). Subconfluent growing BC3H1 cultures contained 
mRNA  which  hybridized  with  this  smooth  muscle  MHC 
probe. As these cells approached confluence, the amount of 
hybridizing  species was diminished  (Fig.  7  A,  lane  1-4). 
Switching subconfluent cultures to LSM also resulted in a 
diminution of this mRNA (Fig. 7 A, lanes 5-8). Duplicate 
blots were hybridized with a cDNA probe encoding an em- 
bryonic skeletal muscle MHC. This probe hybridizes to all 
sarcomeric muscle isoforms, but not to smooth muscle or 
nonmuscle  isoforms  (Wydro  et  al.,  1983).  Subconfluent 
growing BC3H1  cultures  contained very small amounts of 
mRNA hybridizing to this cDNA probe (Fig. 7 B, lane/). 
However, markedly increased amounts of mRNA were seen 
when cells approached confluence (Fig. 7 B, lanes 2-4) or 
when subconfluent cells were switched to LSM (Fig.  7 B, 
lanes 5-8). 
Figure 6. Expression of skeletal muscle MLC and the smooth/non- 
muscle myosin RLC. RNA blot hybridizations using the rat skeletal 
MLC 2 (A and B) and aortic RLC (C and D) eDNA probes. The 
skeletal muscle MLC 2 probe is specific for sareomeric  MLC 2 
mRNAs. The aortic RLC probe hybridizes with sarcomeric MLC 
2 as well as smooth muscle and nonmuscle RLC mRNAs. However, 
the sarcomeric MLC 2 mRNAs can be distinguished on 1% agaros¢ 
gels from the larger  smooth/nonmuscle  RLC mRNAs.  Only the 
bands corresponding to the smooth/nonmuscle mRNAs are shown 
in C and D. (A and C) BC3HI cultures were plated at low density 
and grown in DME + 20% FCS for2, 3, 4, 5, 7, 9, and 11 d (lanes 
1-7, respectively). Cultures appeared confluent 5 d after plating. (B 
and D) Duplicate cultures were grown in DME +  20% FCS and 
subsequently switched to LSM for 48 h, 2, 3, 4, 5, 7, 9, and 11 d 
after plating (lanes 1-7, respectively). 
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RNA blot hybridizations using rabbit smooth (A) muscle and rat 
skeletal muscle (B) MHC probes. The smooth muscle probe hy- 
bridizes strongly only with RNA derived from smooth muscle cells 
or tissues, but does give weak signals with RNA derived from sar- 
comeric and nonmuscle tissues. The skeletal muscle probe is spe- 
cific for sarcomeric RNAs. Cultures were grown in DME  + 20% 
FCS for 2, 4, 6, and 8 d (lanes 1-4, respectively). Cultures appeared 
confluent on day 5. Cultures were switched to LSM for 48 h, 2, 4, 
6, and 8 d after plating (lanes 5-8,  respectively). 
(Fig. 8, A and B, respectively). Growing, but subconfluent, 
BC3H1  cells expressed neither isoform of ot-actin  (Fig.  8, 
lanes I  and 2). However, when cultures reached confluence 
(Fig. 8, lanes 3 and 4) or when subconfluent cultures were 
switched to LSM (Fig.  8, lanes 5 and 6), both cardiac and 
skeletal muscle ct-actin isoforms were expressed. 
The Contractile Protein mRNA Phenotype of 
Differentiated BC3H1 Cells Is Reversible 
It has been demonstrated that the expression of MCK and 
ot-actin mRNAs  in BC3H1  cells is reversible: they can be 
deinduced by either adding growth medium or growth factors 
to subconfluent, induced BC3H1 cultures or by replating in- 
duced cultures at low density in growth medium (Munson et 
al.,  1982; Olson et al.,  1983; Lathrop et al.,  1985; Spizz et 
al.,  1986). Similarly, the expression of the contractile pro- 
tein mRNAs described above was reversible. When conflu- 
ent, induced cultures were replated at low density in growth 
medium,  TnT  (Fig.  9  A)  and  embryonic  skeletal  muscle 
MHC (Fig. 9 F) mRNA levels were significantly decreased 
within 24 h of replating and were absent by 72 h. There was 
a rapid return of the nonmuscle a-Tm isoform and a slower 
loss of the striated muscle isoform (Fig. 9 B). The long time 
courses of disappearance probably reflect the high levels and 
long half-lives (,050  h;  Garfinkel,  1982;  Medford et al., 
1983) of these mRNAs. The deinduction of MLC 3 mRNA 
is likely rendered particularly slow by such a cause. When 
induced, confluent cultures were replated at low density in 
growth medium, there was a very slow loss of MLC 3 mRNA, 
with significant amounts still detectable at 72 h  (Fig. 9  C, 
lanes 1-4).  However, when induced, subconfluent cultures 
were replated at low density in growth medium, there was 
a more rapid loss of MLC 3 mRNA, with little detectable 
at 72 h  (Fig.  9  C,  lanes 5  and 6).  As expected, replating 
resulted in increased levels of the smooth/nonmuscle RLC 
(Fig. 9 D) and nonsarcomeric MHC (Fig. 9 E) mRNAs. 
Discussion 
The results presented above demonstrate that BC3H1 ceils 
exhibit two distinct phenotypes of contractile protein mRNA 
expression. Subconfluent, growing cultures possess predom- 
inantly  nonmuscle or  smooth  muscle  mRNA  isoforms of 
c~-Tm, MHC, and myosin RLC. Under these conditions, they 
have minimal or undetectable levels of mRNA for TnT, or 
sarcomeric muscle isoforms of MHC, MLCs, or o~-Tm. In 
contrast, BC3H1 cultures that are growth arrested either by 
confluency or by switching to a nongrowth (LSM) medium 
express predominantly sarcomeric muscle mRNAs.  These 
include all the sarcomeric mRNAs tested:  TnT and sarco- 
meric muscle isoforms of ot-Tm, MHC, MLC 2, and MLC 
3. In the case of ct-Tm, MHC, and myosin RLC, the induction 
of the  sarcomeric  muscle  isoform is  associated  with  de- 
creased expression of  the smooth or nonmuscle isoform. The 
induced phenotype is reversible: replating BC3H1  cells in 
growth medium results in a loss of sarcomeric muscle and 
the reappearance of nonsarcomeric muscle contractile pro- 
tein mRNAs. 
The pattern of induction of contractile protein mRNAs in 
BC3H1 closely resembles that previously described for sar- 
comeric  myoblasts.  Myoblasts  grown  in  the  presence  of 
sufficient growth factors remain in the proliferative state and 
do not express sarcomeric muscle-specific genes. When the 
concentration of growth factors is reduced, the cells cease 
DNA  synthesis and  begin  to  express  sarcomeric muscle- 
specific genes, including MHC, MLCs, a-actin, a- and/3-Tm, 
and TnT (Devlin and  Emerson,  1978;  Shani et al.,  1981; 
Caravatti et al.,  1982; Garfinkel et al.,  1982; Nadal-Ginard 
et al., 1984). This pattern of contractile protein gene expres- 
sion can occur even in the absence of fusion of myoblasts to 
Figure 8.  Expression of sarcomeric c~-actin isoforms. RNA blot 
hybridizations using cDNA probes from the 3' untranslated region 
of mouse skeletal (A) and 5' untranslated region of mouse cardiac 
(B) a-actin (see Materials and Methods). Cultures were grown in 
DME  +  20% FCS for 1, 3, 5, and 8 d (lanes 1-4, respectively). 
Cultures appeared confluent at day 5. Cultures, grown for 1 d in 
DME +  20% FCS, were switched to LSM for 2 and 4 d (lanes 5 
and 6, respectively). 
The Journal of Cell Biology,  Volume 108, 1989  1804 Figure  9.  Reversibility of contractile protein mRNA expression. 
RNA blot hybridization using the following probes: (A) TnT; (B) 
c~-Tm; (C) skeletal muscle MLC 1 and 3; (D) smooth/nonmuscle 
RLC; (E) embryonic skeletal muscle MHC; and (F) smooth mus- 
cle MHC. Cultures were grown in DME + 20% FCS for 5 d (lane 
1). Duplicates of these confluent, induced cultures were then re- 
plated at low density in DME +  20% FCS for 1, 2, or 3 d (lanes 
2-4, respectively). For MLC 1 and 3 (C), some cultures were also 
grown in DME + 20% FCS for 2 d and then induced by switching 
to LSM for 2 d (lane 5). Duplicate cultures were replated at low 
density and grown in DME +  20% FCS for 72 h (lane 6). 
form  myotubes  (Nguyen  et  al.,  1983;  Endo  and  Nadal- 
Ginard,  1987).  Moreover, the differentiated phenotype can 
be reversible: under the appropriate conditions, myoblasts 
can reenter the cell cycle and concomitantly deinduce the ex- 
pression of the muscle-specific genes (Nguyen et al.,  1983; 
Devlin and Konigsberg,  1983; Nadal-Ginard et al.,  1984). 
In particular, the phenotype of BC3H1 cells closely resem- 
bles  that  of ~Eg-3b2  cells  (Nguyen et  al.,  1983).  These 
cells are temperature sensitive for the commitment to termi- 
nal  differentiation.  At  nonpermissive  temperatures,  L6Eg- 
3b2 cells induce the sarcomeric Contractile protein genes in 
the absence of  cell fusion. Upon serum stimulation, they rap- 
idly deinduce the contractile protein genes and reenter the 
cell cycle. BC3H1 cells thus behave like skeletal myoblasts 
that are defective for commitment to terminal differentiation. 
Like the L~-3b2 cells,  they can reversibly express sarco- 
meric muscle-specific contractile protein genes. 
The finding that differentiated BC3H1 cells produced the 
vascular  smooth  muscle  isoform of ot-actin  (Strauch  and 
Rubenstein,  1984; Strauch et al.,  1986) lent support to the 
speculation that BC3H1  cells were derived from vascular 
smooth muscle.  We have found that BC3H1  cells express 
both cardiac and skeletal muscle c¢-actin mRNA upon induc- 
tion either by serum deprivation or reaching confluence. The 
pattern of expression of actin mRNA in BC3H1 cells is there- 
fore similar to that seen in sarcomeric muscle (Garrels and 
Gibson,  1976;  Whalen et al.,  1976;  Devlin and Emerson, 
1978; Minty et al., 1982; Mohun et al.,  1984). While grow- 
ing, cells express B- and -y-actins;  upon differentiation, they 
switch to sarcomeric ot-actin isoforms. The coexpression of 
the skeletal and cardiac isoforms of a-actin is a common fea- 
ture of  both adult and fetal skeletal and cardiac muscle (Minty 
et al.,  1982; Gunning et al.,  1983; Mayer et al.,  1984; Mo- 
hun  et  al.,  1984;  Paterson  and  Eldridge,  1984).  While 
smooth muscle c~-actin has not been found in skeletal muscle 
tissue, it has been found in dividing mouse L6 (Pinset and 
Whalen,  1984)  and "1984 (Buckingham et al.,  1982)  myo- 
blasts.  Upon differentiation, these cells ultimately express 
the sarcomeric forms of ot-actin. Thus, the presence of smooth 
muscle ot-actin in BC3H1 cells is not inconsistent with these 
cells possessing a predominantly sarcomeric contractile pro- 
tein phenotype upon differentiation. 
The work reported above suggests that the BC3H1 line be- 
haves most like a nonfusing sarcomeric muscle cell, at least 
in regard to the expression of contractile protein genes. This 
is  in agreement with previous findings that these cells ex- 
press other proteins more typical of skeletal muscle, such as 
MCK,  the  nicotinic acetylcholine receptor and  a  skeletal 
muscle voltage-gated Ca  2÷ channel.  BC3H1  cells were de- 
rived from a nitrosoethylurea-induced brain tumor (Schubert 
et  al.,  1974).  Transplantation  experiments  have  demon- 
strated that populations of neural crest cells can give rise to 
a  wide  variety of differentiated adult  cell  types  (Noden, 
1983;  Le Douarin,  1986).  Most significantly, neural crest 
cells are a source of craniofacial skeletal and connective tis- 
sues in the regions formed by frontonasal and branchial arch 
processes (for review see Noden, 1983) and contribute to the 
aorticopulmonary septum (Kirby et al.,  1983).  It has also 
been observed that when the rat neurotumor cell line RT4 is 
treated with 5-azacytidine, a variety of cell types can be iso- 
lated, one of which (RT4-B8) can form myotube-like struc- 
tures and synthesize muscle-type myosin (Tomozawa, Y., un- 
published observations). It is thus apparent that neural tissue 
can give rise to striated muscle and that the BC3HI cell line 
may represent a nonfusing striated muscle cell. One cannot, 
however,  disregard  the  possibility  that  BC3H1  represents 
a  nonsarcomeric muscle cell whose transformation has re- 
sulted  in  its  expression of sarcomeric  contractile protein 
genes. 
The BC3H1  culture system  has  proven of considerable 
value in the study of MCK and actin gene regulation (Olson 
et al.,  1983;  Strauch et al.,  1986;  Wang  and  Rubenstein, 
1988).  We have now demonstrated that a  large battery of 
muscle-specific genes are regulated in BC3H1 cells. These 
include  MHCs,  MLCs,  or-Tin, TnT,  and  the  skeletal  and 
cardiac  isoforms  of ot-actin.  The  BC3H1  culture  system 
should therefore provide an excellent model for studying the 
regulation of  a variety of  contractile protein genes in a milieu 
that allows for the reversible expression of both sarcomeric 
and nonsarcomeric forms. 
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